We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

User-Centered BP Monitor Provides Accurate 24-Hour Readings

By HospiMedica International staff writers
Posted on 30 Mar 2016
The Oscar 2 with SphygmoCor Inside technology
The Oscar 2 with SphygmoCor Inside technology (Photo courtesy of SunTech Medical)
A novel ambulatory blood pressure monitor (ABPM) provides noninvasive measures of central arterial blood pressure waveforms, central aortic blood pressures, and arterial stiffness indices.

The Oscar 2 with SphygmoCor Inside technology is a light, compact monitor that uses motion tolerant algorithms and auto-intelligent inflation to reduce re-inflates and failed readings. The paired Orbit BP cuff, which uses an innovative stretch-sleeve design to maintain cuff placement and promote patient comfort, allows for noninvasive assessment of the central arterial pressure waveform and arterial stiffness, with a transfer function.

The predictive superiority of central arterial pressure waveform analysis using SphygmoCor Inside technology over standard brachial blood pressure is primarily due to the closer proximity of the ascending aorta to important target organs such as the heart, brain, and kidney. The Oscar 2 also includes motion-tolerant technology to help eliminate ambulation and noise artifacts that can cause failed readings and the need for repeated studies. In addition, sub-diastolic waveform measurement delivers a fully-featured physiological waveform with accurate augmentation index.

The ABPM monitor is also designed to be used with proprietary AccuWin Pro 4 software that allows data to be directly exported to a computer database for efficient programming, measurement analysis, and physician interpretation and report. The Oscar 2 was developed as part of a multi-year alliance between SunTech Medical (Morrisville, NC, USA) and AtCor Medical (West Ryde, Australia), and has received the European Community CE marking of approval.

Central arterial blood pressure is the pressure in the aorta, thus representing the pressure that the heart has to pump against to get blood to flow to the rest of the body, including the blood vessels feeding the brain. It has been shown to more strongly relate to vascular disease and outcome—such as stroke and aneurysm—than traditional upper arm (brachial) blood pressure. It also can distinguish between the effects of different hypertension medications when upper arm blood pressure and pulse wave velocity do not.

Related Links:

SunTech Medical
AtCor Medical


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Short Phlebotomy Cart
MSWA-3469-WHT
New
High-Precision QA Tool
DEXA Phantom
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more